Literature DB >> 17019603

PARL Leu262Val is not associated with fasting insulin levels in UK populations.

K A Fawcett1, N J Wareham, J Luan, H Syddall, C Cooper, S O'Rahilly, I N M Day, M S Sandhu, I Barroso.   

Abstract

AIMS/HYPOTHESIS: PARL, the gene encoding presenilins-associated rhomboid-like protein, maps to chromosome 3q27 within a quantitative trait locus that influences components of the metabolic syndrome. Recently, an amino acid substitution (Leu262Val, rs3732581) in PARL was associated with fasting plasma insulin levels in a US white population (N=1031). This variant was also found to modify the positive association between age and fasting insulin. The aim of this study was to test whether these findings could be replicated in two UK population-based cohorts.
METHODS: Participants from the Medical Research Council Ely and Hertfordshire cohort studies were genotyped for this variant using a SNaPshot primer extension assay and Taqman assay respectively. Full phenotypic and genotypic data were available for 3,666 study participants.
RESULTS: Based on a dominant model, we found no association between the Leu262Val polymorphism and fasting insulin levels (p=0.79) or BMI (p=0.98). We did not observe the previously reported interaction between age and genotype on fasting insulin (p=0.14). CONCLUSIONS/
INTERPRETATION: Despite having greater statistical power, our data do not support the previously reported association between PARL Leu262Val and fasting plasma insulin levels, a measure of insulin resistance. Our findings indicate that this variant is unlikely to be an important contributor to insulin resistance in UK populations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17019603      PMCID: PMC2672784          DOI: 10.1007/s00125-006-0443-9

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  9 in total

1.  Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome.

Authors:  A H Kissebah; G E Sonnenberg; J Myklebust; M Goldstein; K Broman; R G James; J A Marks; G R Krakower; H J Jacob; J Weber; L Martin; J Blangero; A G Comuzzie
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

2.  The mitochondrial rhomboid protease PSARL is a new candidate gene for type 2 diabetes.

Authors:  K Walder; L Kerr-Bayles; A Civitarese; J Jowett; J Curran; K Elliott; J Trevaskis; N Bishara; P Zimmet; L Mandarino; E Ravussin; J Blangero; A Kissebah; G R Collier
Journal:  Diabetologia       Date:  2005-02-24       Impact factor: 10.122

3.  Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin, 65-66 split and 32-33 split proinsulins.

Authors:  W J Sobey; S F Beer; C A Carrington; P M Clark; B H Frank; I P Gray; S D Luzio; D R Owens; A E Schneider; K Siddle
Journal:  Biochem J       Date:  1989-06-01       Impact factor: 3.857

4.  Self-regulated cleavage of the mitochondrial intramembrane-cleaving protease PARL yields Pbeta, a nuclear-targeted peptide.

Authors:  Attila Sík; Brent J Passer; Eugene V Koonin; Luca Pellegrini
Journal:  J Biol Chem       Date:  2004-01-19       Impact factor: 5.157

5.  Mitochondrial membrane remodelling regulated by a conserved rhomboid protease.

Authors:  G Angus McQuibban; Saroj Saurya; Matthew Freeman
Journal:  Nature       Date:  2003-05-29       Impact factor: 49.962

6.  A quantitative analysis of the relationship between habitual energy expenditure, fitness and the metabolic cardiovascular syndrome.

Authors:  N J Wareham; S J Hennings; C D Byrne; C N Hales; A M Prentice; N E Day
Journal:  Br J Nutr       Date:  1998-09       Impact factor: 3.718

7.  PAMP and PARL, two novel putative metalloproteases interacting with the COOH-terminus of Presenilin-1 and -2.

Authors:  Luca Pellegrini; Brent J. Passer; Matilde Canelles; Ilyia Lefterov; J. Kelly Ganjei; B.J. Fowlkes; Eugene V. Koonin; Luciano D'Adamio
Journal:  J Alzheimers Dis       Date:  2001-04       Impact factor: 4.472

8.  Cohort profile: the Hertfordshire cohort study.

Authors:  H E Syddall; A Aihie Sayer; E M Dennison; H J Martin; D J P Barker; C Cooper
Journal:  Int J Epidemiol       Date:  2005-06-17       Impact factor: 7.196

9.  The rhomboids: a nearly ubiquitous family of intramembrane serine proteases that probably evolved by multiple ancient horizontal gene transfers.

Authors:  Eugene V Koonin; Kira S Makarova; Igor B Rogozin; Laetitia Davidovic; Marie-Claude Letellier; Luca Pellegrini
Journal:  Genome Biol       Date:  2003-02-28       Impact factor: 13.583

  9 in total
  5 in total

1.  Association of PARL rs3732581 genetic variant with insulin levels, metabolic syndrome and coronary artery disease.

Authors:  Brenda L Powell; Steven Wiltshire; Gillian Arscott; Pamela A McCaskie; Joseph Hung; Brendan M McQuillan; Peter L Thompson; Kim W Carter; Lyle J Palmer; John P Beilby
Journal:  Hum Genet       Date:  2008-08-30       Impact factor: 4.132

2.  Cohort profile: The Hertfordshire Ageing Study (HAS).

Authors:  H E Syddall; S J Simmonds; H J Martin; Clare Watson; E M Dennison; C Cooper; A Aihie Sayer
Journal:  Int J Epidemiol       Date:  2009-01-08       Impact factor: 7.196

Review 3.  The PARL family of mitochondrial rhomboid proteases.

Authors:  R Blake Hill; Luca Pellegrini
Journal:  Semin Cell Dev Biol       Date:  2010-01-04       Impact factor: 7.727

4.  ABCC5 transporter is a novel type 2 diabetes susceptibility gene in European and African American populations.

Authors:  Kenan Direk; Winston Lau; Kerrin S Small; Nikolas Maniatis; Toby Andrew
Journal:  Ann Hum Genet       Date:  2014-09       Impact factor: 1.670

Review 5.  Mitochondrial Processing Peptidases-Structure, Function and the Role in Human Diseases.

Authors:  Nina Kunová; Henrieta Havalová; Gabriela Ondrovičová; Barbora Stojkovičová; Jacob A Bauer; Vladena Bauerová-Hlinková; Vladimir Pevala; Eva Kutejová
Journal:  Int J Mol Sci       Date:  2022-01-24       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.